REQUEST A DEMO
Total
USD $0.00
Search more companies

Qoppa Pharma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Qoppa Pharma Sas Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Qoppa Pharma S.A.S, founded in 2013, is a pharmaceutical laboratory based in Bogotá, Colombia. The company specializes in the manufacturing of oral liquid and semi-solid veterinary products. With over 10,000 employees, they offer finished product coding, lithographic, and packaging services, ensuring high-quality products through compliance with Good Manufacturing Practices

Headquarters
Cr 70 B # 24 Sur 79
Bogota D.C.; Bogota D.C; Postal Code: 0401

Contact Details: Purchase the Qoppa Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Qoppa Pharma Sas report to view the information.
Financial Auditors:
Purchase the Qoppa Pharma Sas report to view the information.
Incorporation Date:
January 18, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Qoppa Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.42%
Total operating revenue
20.42%
Operating Profit/Loss (EBIT)
N/A
Net Profit/Loss for the Period
693.02%
Total Assets
28.82%
Total Equity
101.28%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
7.36%
Return on Equity (ROE)
16.8%
Quick Ratio
-1.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?